Wellbeing Digital Sciences Delivers its First IV Ketamine Treatment Under the Inpatient KITE Program Feb 15, 2022 03:00AM
Ketamine One Changes Name to Wellbeing Digital Sciences Jan 24, 2022 03:00AM
Ketamine One Becomes Exclusive Ketamine Treatment Provider to Victoria Wellness Jan 17, 2022 03:00AM
Ketamine One Begins Trading on the OTCQB Marketplace on January 12, 2022 Jan 12, 2022 03:00AM
Ketamine One Subsidiary KGK Science Becomes the First Founding Sponsor of the “Psychedelic Science 2023” Event Jan 10, 2022 03:00AM


Jan 5, 2022 03:00AM Ketamine One Appoints Two New Members to Its Medical Advisory Board
Dec 20, 2021 11:11AM Ketamine One Announces 2021 AGSM Results
Dec 16, 2021 03:00AM Ketamine One Reports Strong 1Q22 Financial Results
Dec 15, 2021 07:00AM Ketamine One Announces Lifting of Management Cease Trade Order
Dec 14, 2021 05:00PM Ketamine One Appoints Joe Ramelli as Its New Chief Financial Officer
Dec 13, 2021 05:00PM Ketamine One Reports Audited Financial Results for the 2021 Fiscal Year
Dec 8, 2021 03:00AM KetamineOne Adds Seattle Location to US Clinical Network
Dec 2, 2021 05:00PM KetamineOne Subsidiary KGK Science Helps Client Receive New Dietary Ingredient Status from U.S. FDA
Nov 29, 2021 07:00AM Ketamine One Provides Second Update on Management Cease Trade Order
Nov 16, 2021 03:00AM Ketamine One Subsidiary IRP Health Opens Two New Veteran-Focused Clinics
Nov 15, 2021 06:00PM Ketamine One Provides Update on Management Cease Trade Order
Nov 9, 2021 03:00AM Ketamine One Announces Intention to Submit Draft Registration Statement for Proposed U.S. Initial Public Offering
Nov 4, 2021 06:00PM Ketamine One Announces Resignation of Loreto Grimaldi From Board of Directors
Nov 4, 2021 03:00AM Ketamine One Announces Virtual Mental Healthcare Platform in Partnership With iHealthOX
Nov 1, 2021 07:04PM Ketamine One Announces Late Filing of Annual Financial Statements and Management Cease Trade Order